12:00 AM
Nov 12, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Medicure, Seyer sales and marketing update

Medicure's Medicure Pharma Inc. subsidiary granted Seyer exclusive rights to commercialize Aggrastat tirofiban in Puerto Rico. Seyer will launch the non-peptide Integrin alpha(2b)beta(3) (GPIIb/IIIa) (CD41/CD61) antagonist...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >